Adam D. Cutler

Chief Financial Officer, Molecular Templates, Inc.

Companies

Mural Oncology plcChief financial officer Nov 15, 2023 to now¹
InMed Pharmaceuticals Inc.Board member Nov 12, 2020 to Jan 24, 2022²
Molecular Templates, Inc.Officer Jun 4, 2018 to Feb 17, 2021³
NAVIDEA BIOPHARMACEUTICALS, INC.Board member Dec 11, 2018 to Jan 14, 2021⁴
Molecular Templates, Inc.Chief financial officer Nov 15, 2017 to Nov 15, 2017⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Mural Oncology plc0 shares⁶Dec 5, 2025

As of each latest filing. The line shows shares held over time.

Recent filings

Dec 5, 2025Returned to company 99,290 shares of Mural Oncology plc⁶
Nov 3, 2025Sold 7,148 shares at $2.09 of Mural Oncology plc⁷
Mar 3, 2025Granted 35,000 shares of Mural Oncology plc⁸
Oct 31, 2024Sold 7,421 shares at $3.41 of Mural Oncology plc⁹
Dec 14, 2023Granted 78,859 shares of Mural Oncology plc¹⁰

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARMural Oncology plc, Chief financial officer
2
SEC EDGARInMed Pharmaceuticals Inc., Board member
3
SEC EDGARMolecular Templates, Inc., Officer
4
SEC EDGARNAVIDEA BIOPHARMACEUTICALS, INC., Board member
5
SEC EDGARMolecular Templates, Inc., Chief financial officer
6
SEC EDGARMural Oncology plc shares after the filing of Dec 5, 2025
7
SEC EDGARForm 4 filed Nov 10, 2025
8
SEC EDGARForm 4 filed Mar 5, 2025
9
SEC EDGARForm 4 filed Nov 1, 2024
10
SEC EDGARForm 4 filed Dec 18, 2023